Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4I431
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0030627 | pre-mRNA 5'-splice site binding | 6 | 1 |
GO:0036002 | pre-mRNA binding | 5 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.413 |
CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 248 | 252 | PF00082 | 0.332 |
DEG_SPOP_SBC_1 | 230 | 234 | PF00917 | 0.412 |
DEG_SPOP_SBC_1 | 5 | 9 | PF00917 | 0.440 |
DOC_MAPK_gen_1 | 144 | 151 | PF00069 | 0.430 |
DOC_SPAK_OSR1_1 | 107 | 111 | PF12202 | 0.288 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.405 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.291 |
DOC_USP7_MATH_1 | 230 | 234 | PF00917 | 0.518 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.368 |
LIG_14-3-3_CanoR_1 | 211 | 216 | PF00244 | 0.495 |
LIG_Actin_WH2_2 | 89 | 105 | PF00022 | 0.370 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.415 |
LIG_BRCT_BRCA1_1 | 128 | 132 | PF00533 | 0.358 |
LIG_CSL_BTD_1 | 255 | 258 | PF09270 | 0.375 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.375 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.250 |
LIG_FHA_1 | 283 | 289 | PF00498 | 0.372 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.373 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.489 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.345 |
LIG_LIR_Gen_1 | 164 | 174 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.415 |
LIG_LIR_Nem_3 | 164 | 170 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.424 |
LIG_SH2_GRB2like | 19 | 22 | PF00017 | 0.424 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 307 | 310 | PF00017 | 0.340 |
LIG_SH3_3 | 260 | 266 | PF00018 | 0.442 |
LIG_SUMO_SIM_par_1 | 271 | 276 | PF11976 | 0.429 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.361 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.422 |
MOD_CK1_1 | 292 | 298 | PF00069 | 0.380 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.335 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.506 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.416 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.416 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.511 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.417 |
MOD_GlcNHglycan | 294 | 297 | PF01048 | 0.343 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.205 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.531 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.454 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.531 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.401 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.310 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.428 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.302 |
MOD_N-GLC_1 | 297 | 302 | PF02516 | 0.418 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.462 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.360 |
MOD_NEK2_1 | 229 | 234 | PF00069 | 0.385 |
MOD_NEK2_1 | 297 | 302 | PF00069 | 0.418 |
MOD_NEK2_2 | 284 | 289 | PF00069 | 0.543 |
MOD_PIKK_1 | 223 | 229 | PF00454 | 0.447 |
MOD_PKA_2 | 126 | 132 | PF00069 | 0.326 |
MOD_PKB_1 | 101 | 109 | PF00069 | 0.454 |
MOD_Plk_1 | 297 | 303 | PF00069 | 0.431 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.358 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.312 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.401 |
TRG_DiLeu_BaEn_1 | 247 | 252 | PF01217 | 0.472 |
TRG_DiLeu_BaEn_1 | 45 | 50 | PF01217 | 0.220 |
TRG_DiLeu_BaLyEn_6 | 233 | 238 | PF01217 | 0.351 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.424 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5J8 | Leptomonas seymouri | 61% | 100% |
A0A1X0NQJ3 | Trypanosomatidae | 34% | 100% |
A0A3S7X1X9 | Leishmania donovani | 100% | 72% |
A0A422NG23 | Trypanosoma rangeli | 37% | 100% |
A4HGZ9 | Leishmania braziliensis | 85% | 100% |
D0A8X8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 99% |
E9B0B8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
O94620 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 95% |
Q4Q7W6 | Leishmania major | 93% | 100% |
V5BDN5 | Trypanosoma cruzi | 38% | 100% |